Johnathan M. Lancaster, MD, PhD
Director, Center for Women's Oncology, Chair, Department of Women's Oncology
H. Lee Moffitt Cancer Center
12902 Magnolia Drive - MCC
Tampa,
FL
USA
33612-9497
Papers:
181
Molecular signaling pathways associated with squamous-cell carcinoma of the cervix cisplatin-resistance
250
Therapeutic dilemma: prognostic factors and outcome for patients with neuroendocrine tumors of the cervix
286
Unique molecular portraits of ovarian cancer: implications for prognostics and targeted therapeutics
340
AKT survival signaling and phospho-AKT expression are associated with triple negative breast cancer development and clinical outcome
361
The BAD apoptotic pathway: a cervical cancer therapeutic target associated with disease development, therapeutic response and patient survival
422
The impact of depression on survival in uterine carcinosarcoma
437
AKT survival signaling as a determinant of ovarian cancer chemoresistance and clinical outcome
441
Vitamin D suppresses ovarian cancer invasion by inhibiting cytokine expression and NFκB signaling
471
Distance to specialist care is associated with survival in patients with gynecologic malignancies
475
Complementary and alternative medicine use in patients with gynecologic cancers
515
Repurposing Artesunate, an anti-malarial, for ovarian cancer treatment: mechanistic insights from cell line models